Drug Database
Back to search

Japan· JP-6132011F1080

セフポドキシム　プロキセチル

A medicinal product containing セフポドキシム プロキセチル, registered in Japan by 第一三共, on the national reimbursement list.

On Japan’s NHI price list

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedセフポドキシム　プロキセチルATC—REGISTER NO.JP-6132011F1080PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about セフポドキシム プロキセチルAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

MHLW / PMDA (Japan)
Active substance
セフポドキシム プロキセチル
Manufacturer
第一三共
Country
Japan (JP)
ATC code
—
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

セフポドキシム プロキセチル in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All セフポドキシム プロキセチル products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Austria · Biocef
  • Bulgaria · Ximebac, Фоксеро
  • Czechia · Forexo
  • Germany · Cefpodoxim 1 A Pharma, Cefpodoxim Al
  • France · Cefpodoxime Biogaran, Cefpodoxime Cristers Pharma
  • United Kingdom (Northern Ireland) · Cefpodoxime Proxetil, Cefpodoxime Proxetil Sandoz
  • Croatia · Rexocef
  • Italy · Cefpodoxima Mylan, Cefpodoxima Sandoz
  • Portugal · Cefpodoxima Alkaloid
  • Romania · Forexo
  • Slovenia · Trexodo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/023a2722-b9ad-4d21-aedc-883009cf29b6
GET /v1/drugs/023a2722-b9ad-4d21-aedc-883009cf29b6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "１００ｍｇ１錠",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "6132011F1080",
  "category": "内用薬",
  "price_yen": 36.4,
  "generic_name": "セフポドキシム　プロキセチル",
  "product_name_jp": null,
  "therapeutic_class": "6132",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about セフポドキシム プロキセチル.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console